Language

English

Publication Date

6-17-2025

Journal

Cell Reports Medicine

DOI

10.1016/j.xcrm.2025.102154

PMID

40480221

PMCID

PMC12208316

PubMedCentral® Posted Date

6-5-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Proteogenomic analysis is applied to samples from the CALGB 40601 (Alliance) randomized neoadjuvant trial of trastuzumab, lapatinib, or the combination to identify biomarkers associated with pathological response status. Absence of ERBB2 gene amplification and human epidermal growth factor receptor 2 (HER2) protein overexpression by proteogenomics is associated with non-pathological compete response (pCR) (p < 0.05), highlighting potential false positives from standard diagnostics. Pathway analysis in proteogenomics-confirmed HER2+ samples identifies elevated epithelial-mesenchymal transition (EMT) and WNT-β-catenin signaling in non-pCR cases before treatment. Twenty-four pCR-associated proteins reproduce in a second proteomic dataset, and four (GPRC5A, TPBG, SP140L, and NEU1) are significant in a third. A meta-analysis of ten diverse neoadjuvant anti-HER2 treatment regimens from four independent studies confirms that non-pCR cases express higher levels of mRNA for G protein-coupled receptor class C group 5 member A (GPRC5A, p = 0.0002) and trophoblast glycoprotein (TPBG, p = 0.00008). Thus, proteogenomic analysis identifies negative biomarkers for pCR and alternative plasma membrane targets for treatment-resistant HER2+ breast cancer.

Keywords

Female, Humans, Biomarkers, Tumor, Breast Neoplasms, Drug Resistance, Neoplasm, Epithelial-Mesenchymal Transition, Lapatinib, Neoadjuvant Therapy, Proteogenomics, Receptor, ErbB-2, Trastuzumab

Comments

This trial is registered at clinicaltrials.gov (NCT00770809).

Published Open-Access

yes

Additional Files
fx1.jpg (298 kB)
Graphical Abstract
Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.